The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

All News

DuPont to Provide Probiotics for International Pediatric Sepsis Research
Biotics and Supplements

DuPont to Provide Probiotics for International Pediatric Sepsis Research

APR 26, 2019
Interview with Nicola Segata, Winner of the Institut Mérieux – Pharmabiotics 2019 YIA Awards
Editor's Choice

Interview with Nicola Segata, Winner of the Institut Mérieux – Pharmabiotics 2019 YIA Awards

APR 17, 2019
Biomica Initiates Pre-clinical Studies in Its Immuno-oncology Program
Oncology

Biomica Initiates Pre-clinical Studies in Its Immuno-oncology Program

APR 17, 2019
Microbiome Profiling Techniques Reveal Effects of Iron Fortification on the Infant Gut Microbiome
Editor's Choice

Microbiome Profiling Techniques Reveal Effects of Iron Fortification on the Infant Gut Microbiome

APR 16, 2019
Flagship Pioneering Unveils Kintai Therapeutics
Finance

Flagship Pioneering Unveils Kintai Therapeutics

APR 16, 2019
MaaT Pharma Announces Second Positive DSMB Safety Assessment of Phase II HERACLES Study in Acute GvHD
Clinical & Manufacturing

MaaT Pharma Announces Second Positive DSMB Safety Assessment of Phase II HERACLES Study in Acute GvHD

APR 11, 2019
SkinBiotix® Shows Efficacy in First Human Study
Pharma & Human Health

SkinBiotix® Shows Efficacy in First Human Study

APR 8, 2019
Interview With Aoife Brennan, CEO, Synlogic Inc
Biotics and Supplements

Interview With Aoife Brennan, CEO, Synlogic Inc

APR 7, 2019
C3J Therapeutics Announces Issuance of U.S. Patent Covering Synthetic Bacteriophage
Pharma & Human Health

C3J Therapeutics Announces Issuance of U.S. Patent Covering Synthetic Bacteriophage

APR 3, 2019
The Human Microbiome: A Diversity of Players Ranging from Academics to Dedicated Platforms
Clinical & Manufacturing

The Human Microbiome: A Diversity of Players Ranging from Academics to Dedicated Platforms

APR 3, 2019
Lonza and Chr. Hansen in Joint Venture to Accelerate Momentum in Microbiome
Finance

Lonza and Chr. Hansen in Joint Venture to Accelerate Momentum in Microbiome

APR 2, 2019